Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 27;10(6):347.
doi: 10.3390/diagnostics10060347.

Comparison between Diffusion-Weighted Sequences with Selective and Non-Selective Fat Suppression in the Evaluation of Crohn's Disease Activity: Are They Equally Useful?

Affiliations

Comparison between Diffusion-Weighted Sequences with Selective and Non-Selective Fat Suppression in the Evaluation of Crohn's Disease Activity: Are They Equally Useful?

Ilze Apine et al. Diagnostics (Basel). .

Abstract

Background: We compared the efficiency of two MRI diffusion weighted imaging (DWI) techniques: DWI with SPIR (DWISPIR) and DWI with STIR (DWISTIR), to estimate their eligibility for quantitative assessment of Crohn's disease activity in children and adults. Methods: In inflamed terminal ileum segments (n = 32 in adults, n = 46 in children), Magnetic Resonance Index of Activity (MaRIA) was calculated, ADC values of both DWI techniques were measured, and the corresponding Clermont scores calculated. ADC values of both DWI techniques were compared between both and within each patient group, assessing their mutual correlation. Correlations between MaRIA and the corresponding ADC values, and Clermont scores based on both DWI techniques were estimated. Results: No correlation between ADC of DWISPIR and DWISTIR was observed (rho = 0.27, p = 0.13 in adults, rho = 0.20, p = 0.17 in children). The correlation between MaRIA and Clermont scores was strong in both techniques-in SPIR, rho = 0.93; p < 0.0005 in adults, rho = 0.98, p < 0.0005 in children, and, in STIR, rho = 0.89; p < 0.0005 in adults, rho = 0.95, p < 0.0005 in children. The correlation between ADC and MaRIA was moderate negative for DWISTIR (rho = 0.93, p < 0.0005 in adults, rho = 0.95, p < 0.0005 in children), but, in DWISTIR, no correlation between ADC and MaRIA score was observed in adults (rho = -0.001, p = 0.99), whereas children presented low negative correlation (rho = -0.374, p = 0.01). Conclusions: DWISTIR is not suitable for quantitative assessment of Crohn's disease activity both in children and adult patients.

Keywords: ADC; Clermont score; DWI; DWI fat suppression techniques.; DWIBS; MR enterography; MaRIA; diffusion-weighted imaging; terminal ileitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison of (a) ADC-DWISPIR values, and (b) ADC-DWISTIR values between adults and children.
Figure 2
Figure 2
Comparison between ADC-DWISPIR and ADC-DWISTIR values in the (a) adult group and (b) in children.
Figure 3
Figure 3
Correlation curve between ADC-DWISPIR and ADC-DWISTIR in adults (a) and children (b) showing no correlation.
Figure 4
Figure 4
Correlation curve between MaRIA and ADC-DWISPIR—based Clermont score in adults (a) and children (b) showing high correlation.
Figure 5
Figure 5
Correlation curve between MaRIA and ADC-DWISTIR—based Clermont score in adults (a) and children (b) showing high correlation.
Figure 6
Figure 6
Correlation curve between ADC-DWISPIR and MaRIA in adults (a) and children (b) showing moderate negative correlation.
Figure 7
Figure 7
Correlation curve between ADC-DWISTIR and MaRIA in adults (a) showing no correlation and in children (b) showing low negative correlation.
Figure 8
Figure 8
DWISPIR (a) and DWISTIR (b) tracking images of b = 800 s/mm2 images of 40 years old male patient with active CD. Inflamed bowel walls present high signal intensity. Despite decreased SNR causing graininess in the images, the resolution of inflamed bowel and delineation of contours is better in DWISTIR image (black arrow) as compared to the DWISPIR image (white arrow).
Figure 9
Figure 9
Inflammation of the ileal wall in active chronic CD in 14 y.o. boy, hematoxylin-eosin staining (courtesy of Dr. Ivars Melderis), (a) at magnification× 40, (b) at magnification× 100. Infiltration by plasma cells, neutrophils and abundant number of lymphocytes is present in the mucosal part of the bowel (star), along with epithelioid granuloma (arrow) in the lamina muscularis mucosae providing additional contribution for restricted diffusion signal in DWI images in children CD. Due to granulation process, there are unaltered red blood cells (arrowheads) in the capillaries of intestinal mucosa. The presence of blood degradation products is not detectable in any of the intestinal wall layers.

Similar articles

Cited by

References

    1. Dulai P.S., Singh S., Cesarini M., Bouguen G., Nelson S.A., Peyrin-Biroulet L., Feagan B.G., Ordas I., Sandborn W.J., Santillan C., et al. Cochrane Database of Systematic Reviews MRI scoring indices for evaluation of disease activity and severity in Crohn ’ s disease (Methodology Protocol) Cochrane Database Syst. Rev. 2015;4:1–8.
    1. Cosnes J., Gowerrousseau C., Seksik P., Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794. doi: 10.1053/j.gastro.2011.01.055. - DOI - PubMed
    1. Sakuraba H., Ishiguro Y., Hasui K., Hiraga H., Fukuda S., Shibutani K., Takai Y. Prediction of maintained mucosal healing in patients with Crohn’s disease under treatment with infliximab using diffusion-weighted magnetic resonance imaging. Digestion. 2014;89:49–54. doi: 10.1159/000356220. - DOI - PubMed
    1. Peyrin-Biroulet L., Sandborn W., Sands B.E., Reinisch W., Bemelman W., Bryant R.V., D’Haens G., Dotan I., Dubinsky M., Feagan B., et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am. J. Gastroenterol. 2015;110:1324–1338. doi: 10.1038/ajg.2015.233. - DOI - PubMed
    1. Maaser C., Sturm A., Vavricka S.R., Kucharzik T., Fiorino G., Annese V., Calabrese E., Baumgart D.C., Bettenworth D., Borralho Nunes P., et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J. Crohn’s Colitis. 2019;13:144K–164K. doi: 10.1093/ecco-jcc/jjy113. - DOI - PubMed

LinkOut - more resources